Infinium Global Research Respiratory Drugs Market | Page 2

A latest report has been added to the wide database of Respiratory Drugs Market by Infinium Global Research. This report studies the
Respiratory Drugs Market by disease (COPD, pulmonary hypertension, asthma, cystic fibrosis, allergic rhinitis and idiopathic pulmonary
fibrosis), region (North America, Europe, Asia-Pacific, Rest of the World) market status and outlook of global and major regions, from
manufacturers, and end industries. The objective of the study is to identify market sizes of different segments & countries in recent
years and to forecast the values for the next six years. Respiratory Drugs Market provides opportunities in micro markets for
stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major
companies in the Respiratory Drugs Market. According to report the global respiratory drugs market is projected to grow at a CAGR of
7.1% over the forecast period of 2018-2024.
Segment Covered
The report on global respiratory drugs market covers disease segments. On the basis of disease the global respiratory drugs market is
categorized into COPD, pulmonary hypertension, asthma, cystic fibrosis, allergic rhinitis and idiopathic pulmonary fibrosis.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this
section the key trends and market size for each geography is provided over the period of 2016-2024. The countries covered in the
North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the
growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the
market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a
CAGR of x.x% over the period of 2018-2024.
Companies Profiled:
The report provides profiles of the companies in the global respiratory drugs market such as, FibroGen, Amgen, Dr. Reddy's
Laboratories, Afferent Pharmaceuticals, Dainippon Sumitomo, Abbott, Horizon Pharma, Amgen, Pfizer and FibroGen.